Bio-Techne Corporation

BOVESPA:T1CH34 Stock Report

Market Cap: R$65.8b

Bio-Techne Future Growth

Future criteria checks 4/6

Bio-Techne is forecast to grow earnings and revenue by 21.2% and 8.8% per annum respectively. EPS is expected to grow by 20.3% per annum. Return on equity is forecast to be 13.8% in 3 years.

Key information

21.2%

Earnings growth rate

20.3%

EPS growth rate

Life Sciences earnings growth0%
Revenue growth rate8.8%
Future return on equity13.8%
Analyst coverage

Good

Last updated31 Oct 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

BOVESPA:T1CH34 - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/20271,4873257206058
6/30/20261,33826137142113
6/30/20251,22319829534714
9/30/20241,172151245303N/A
6/30/20241,159168236299N/A
3/31/20241,154203251307N/A
12/31/20231,145224225276N/A
9/30/20231,144247215258N/A
6/30/20231,137285216254N/A
3/31/20231,124271233274N/A
12/31/20221,120262252296N/A
9/30/20221,118292285333N/A
6/30/20221,106272280325N/A
3/31/20221,076225302345N/A
12/31/20211,030210308346N/A
9/30/2021985177295335N/A
6/30/2021931140308352N/A
3/31/2021848184225275N/A
12/31/2020799175201250N/A
9/30/2020760248179231N/A
6/30/2020739229153205N/A
3/31/2020755187170216N/A
12/31/2019745195165207N/A
9/30/201973493151183N/A
6/30/201971496156182N/A
3/31/2019703121171191N/A
12/31/201868296154173N/A
9/30/2018661128145165N/A
6/30/2018643126N/A170N/A
3/31/2018619112N/A156N/A
12/31/2017599114N/A160N/A
9/30/201757773N/A162N/A
6/30/201756376N/A144N/A
3/31/201754174N/A129N/A
12/31/201652882N/A141N/A
9/30/2016517101N/A138N/A
6/30/2016499104N/A144N/A
3/31/2016482105N/A145N/A
12/31/201546599N/A138N/A
9/30/2015456107N/A135N/A
6/30/2015452108N/A139N/A
3/31/2015427108N/A140N/A
12/31/2014408116N/A144N/A
9/30/2014380107N/A140N/A
6/30/2014358111N/A137N/A
3/31/2014345113N/A129N/A
12/31/2013330114N/A127N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: T1CH34's forecast earnings growth (21.2% per year) is above the savings rate (10.4%).

Earnings vs Market: T1CH34's earnings (21.2% per year) are forecast to grow faster than the BR market (12.6% per year).

High Growth Earnings: T1CH34's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: T1CH34's revenue (8.8% per year) is forecast to grow faster than the BR market (7.4% per year).

High Growth Revenue: T1CH34's revenue (8.8% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: T1CH34's Return on Equity is forecast to be low in 3 years time (13.8%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y